Ultra-high resolution and ultra-sensitive fluorescence methods for objective sub-cellular diagnosis of early disease and disease progression in breast and prostate cancer.09:00-09:10 Introduction and overview of the aims of the FLUODIAMON project. (J. Widengren, KTH Stockholm) 09:10-10:00 Breast and prostate cancer – a clinical orientation. (L. Löfgren, KI Stockholm; H. Jorulf, Uppsala Univ.) 10:00-10:20 Diagnostic sampling by Fine-Needle-Aspiration – needle development and anti-seeding procedures. (G. Auer, KI; H. Wiksell, NeoDynamics AB) 10:20-10:50 The Human Protein Atlas project. (S. Hober, KTH) 10:50-11:05 Affinity molecules for subcellular diagnostics. (P.Å. Nygren; A. Karlström-Eriksson, KTH; S. van der Maarel, Leiden Univ. Medical Center, Netherlands) 11:05-11:20 Coffee break 11:20-11:50 Stimulated Emission Depletion (STED) imaging. (S.W. Hell, Max Plank Inst., Göttingen, Germany) 11:50-12:10 Multiparameter Fluorescence Detection imaging (MFDi). (C.A.M. Seidel, Heinrich Heine Univ. Düsseldorf, Germany) 12:10-12:30 Image analysis. (V. Rantanen, Univ. of Helsinki) 12:30-12:55 First images on cultured cells and FNA samples within the FLUODIAMON project. 12:55-13:00 Concluding remarks. This workshop is organized by the FLUODIAMON project and supported by funds from the European Union 7th Framework Programme.